Atheroclef® (ATHEROKLEPHYT®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbspextract for ingestion liquid
Composition:

To obtain 1000 ml of the drug, use:

Active ingredient: clover grass 500 g;

auxiliary substance: Ethanol (ethyl alcohol) 40% is sufficient to produce 1000 ml of the preparation.

Description:

The liquid is light to dark brown with a specific odor. During storage, a deposit may occur.

Pharmacotherapeutic group:Lipid-lowering agent of plant origin
ATX: & nbsp
  • Other
    • Pharmacodynamics:

    Atherolefit® is a liquid extract of red clover grass, obtained by double extraction of raw materials with 40% ethanol.

    According to the results of preclinical studies, the liquid extract of red clover grass has a moderate lipid-lowering effect: it helps to reduce the concentration of total cholesterol, the concentration of low-density lipoprotein (LDL), and increase the concentration of high-density lipoprotein (HDL).

    The mechanism of action of the liquid extract of red clover grass is associated with the redistribution of LDL cholesterol in HDL cholesterol, in which cholesterol is metabolized more quickly and is excreted from the body.

    Liquid extract of red clover grass also helps to reduce the intensity of lipid peroxidation,as a result of which the peroxide modification of lipoproteins decreases and the permeability of the vascular wall is normalized.

    Indications:

    Hyperlipidemia IIbut of the Frederickson type, weakly expressed.

    Contraindications:

    Hypersensitivity to the components of the drug, age to 18 years, brain injury, brain diseases, liver disease, severe renal dysfunction, alcoholism.

    Carefully:

    Apply to patients with impaired renal function of mild and moderate severity.

    Persons who have chronic diseases should consult a doctor before using the drug.

    Pregnancy and lactation:

    The drug is contraindicated for use during pregnancy and during breastfeeding. If it is necessary to prescribe the drug during lactation, breastfeeding should be discontinued.

    Dosing and Administration:

    Inside: 1 teaspoon of the drug, previously diluted in 1/3 cup water, 3 times a day for 30 minutes before meals. The course of treatment is 3-6 months.

    Conducting a second course of treatment is possible on the recommendation of a doctor.

    Before prescribing the drug, the patient should be transferred to a hypocholesterolemic diet, which must be observed during the entire period of therapy.

    Side effects:

    There may be allergic reactions (itching, rash), as well as nausea, headache, a feeling of bitterness in the mouth.

    If side effects occur, including those not listed in the instructions, discontinue use and consult a doctor.

    Overdose:

    When the drug is used in doses exceeding the recommended dosage, dose-dependent side effects may increase, signs of alcohol intoxication (dizziness, nausea, vomiting).

    Treatment is symptomatic.

    Interaction:

    At present, there is no data on the interaction of the drug Atherolefit® when it is used together with other drugs, in particular, with hypolipidemic drugs.

    Special instructions:

    Before you start using the drug, you should consult your doctor.

    During the therapy with the drug Atheroklef®, it is necessary to control the activity of "liver" transaminases, creatine phosphokinase, control of kidney function.

    To this end, during the period of taking the drug Atheroklef® it is recommended to visit the doctor at least once a month in order to correct therapy if necessary. The number and timing of visits are determined by the attending physician.

    The content of ethanol in the preparation is at least 35%. A single dose of the drug (1 teaspoon) contains 1.58 grams of absolute ethyl alcohol, the maximum daily dose (3 teaspoons) contains 4.74 grams of absolute ethyl alcohol.

    Do not exceed the indicated daily dose.

    Women of childbearing age should use reliable methods of contraception when using the drug.

    Effect on the ability to drive transp. cf. and fur:During the period of treatment with the drug Atheroklef® it is necessary to refrain from driving vehicles and taking other potentially dangerous activities that require a high concentration of attention and speed of psychomotor reactions.
    Form release / dosage:Extract for oral administration is liquid.
    Packaging:

    30, 50 or 100 ml bottles of brown or amber glass for medicines, sealed with screw-caps with a sealing member and first opening control.

    Each bottle, together with instructions for use, is placed in a pack of cardboard.

    Storage conditions:

    At a temperature of no higher than 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    2 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LP-001518
    Date of registration:16.02.2012 / 17.02.2017
    Expiration Date:Unlimited
    Date of cancellation:2017-02-16
    The owner of the registration certificate:EVALAR, CJSC EVALAR, CJSC Russia
    Manufacturer: & nbsp
    Representation: & nbspEVALAR CJSC EVALAR CJSC Russia
    Information update date: & nbsp08.10.2017
    Illustrated instructions
      Instructions
      Up